Fifth Third Bancorp’s OptimizeRx OPRX Stock Holding History

Fifth Third Bancorp’s Portfolio OPRX Stock Details OPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-39	Closed	-$245	–	4425
2026 Q1	$245	Buy	+39	New	+$362	﹤0.01%	4236
2022 Q3	–	Sell	-278	Closed	-$8K	–	2723
2022 Q2	$8K	Buy	278 +223	+405%	+$6.61K	﹤0.01%	2084
2022 Q1	$2K	Buy	+55	New	+$2.43K	﹤0.01%	2540
2020 Q4	–	Sell	-14,934	Closed	-$311K	–	2424
2020 Q3	$311K	Sell	14,934 -36,400	-71%	-$625K	﹤0.01%	742
2020 Q2	$669K	Hold	51,334	–	–	﹤0.01%	579
2020 Q1	$465K	Hold	51,334	–	–	﹤0.01%	610
2019 Q4	$527K	Hold	51,334	–	–	﹤0.01%	637
2019 Q3	$743K	Hold	51,334	–	–	﹤0.01%	565
2019 Q2	$832K	Sell	51,334 -7,000	-12%	-$94.5K	0.01%	540
2019 Q1	$742K	Hold	58,334	–	–	﹤0.01%	536
2018 Q4	$640K	Buy	58,334 +7,000	+14%	+$104K	﹤0.01%	549
2018 Q3	$924K	Hold	51,334	–	–	0.01%	524
2018 Q2	$534K	Buy	+51,334	New	+$528K	﹤0.01%	671

Other funds holding OPRX

WCA

Whetstone Capital Advisors Shawnee Mission, Kansas $380M AUM 20.01% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

KCM

Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return

Fifth Third Bancorp's OPRX Position: Q2 2026 in Review

Fifth Third Bancorp sold out of OptimizeRx (OPRX) in Q2 2026, closing a stake of 39 shares — an estimated $245 sold.

Fifth Third Bancorp first reported a position in OPRX in Q2 2018 and held it in 13 quarters. The position peaked at $924K in Q3 2018. 113 funds tracked by Wall St. Rank hold OPRX as of Q2 2026.

Fifth Third Bancorp reported no remaining OptimizeRx position as of Q2 2026 after selling out during the quarter.
Fifth Third Bancorp sold 39 OptimizeRx shares in Q2 2026, an estimated $245.
Fifth Third Bancorp first reported a position in OptimizeRx in Q2 2018 and held it in 13 quarters.
Fifth Third Bancorp's OptimizeRx position peaked at $924K in Q3 2018.
113 funds tracked by Wall St. Rank held OptimizeRx as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.